Drug Approval | March 19, 2023
Bliss GVS Pharma gets 3 minor observations from USFDA for Palghar unit
The observations are procedural in nature
The observations are procedural in nature
Expands robotics to 20+ specialities
Biocorp will receive an initial milestone payment this year
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Marksans' OTC Famotidine Tablets USP are acid reducers
Subscribe To Our Newsletter & Stay Updated
